drugset / Trial / NCT01559259

Evaluation of the Efficacy of Novel Ibuprofen Acetaminophen Combination Formulations in the Treatment of Post-surgical Dental Pain

NCT01559259 ↗

Phase 2 Completed 394 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will determine the overall analgesic efficacy of three different fixed dose ibuprofen plus acetaminophen formulations compared to ibuprofen alone and to placebo.

Timeline

Start
2012-04-10
Primary completion
2012-09-13
Completion
2012-09-13

Outcome

Met primary endpoint

paper All active treatments were superior to placebo for SPRID[4]0-8 (all p < 0.001) PMID 32506309 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 500 mg —
Subject Ibuprofen Small molecule 200 mg —
Subject Ibuprofen Small molecule 250 mg —
Subject Ibuprofen Small molecule 300 mg —
Subject Ibuprofen Small molecule 400 mg —

Indications

No indication recorded.